Jason Hope Take on Longevity Research

Advancing longevity is a topic surrounded by many myths. For example, some say living a healthy life is enough to extend longevity, while others believe it is impossible to live past a certain age. Scientists have it that learning about stem cells can help extend human longevity. With avid researchers and promising scientific findings, there is an increased number of biotech and startups steering stem cell related projects (Finance). 

 

Jason Hope on Stem Cell Research

 

The interconnection between technology and medicine continues to evolve, and the stem cells topic will remain relevant. In the last two decades, scientists have managed to extract human embryonic cells and grew the cells in a lab setting. The successful process of growing the parent cells that later allow the growth of new cells in the human body was a remarkable milestone for medical personnel involved in creating effective regenerative treatments for stroke, Alzheimer’s, heart disease, and Parkinson’s Disease. Though the milestone was promising, futurist entrepreneur Jason Hope points out, the medical fraternity is yet to make notable strides in taking stem cell therapy to the market. The research needs to be backed up by evidence for it to be acceptable in the market. 

 

As of now, the only implemented stem cell treatments are related to successfully growing blood cells extracted from donors for patients suffering from blood disorders. According to a renowned entrepreneur, an expert in longevity and anti-aging and philanthropist, Jason Hope, the initial implementation of stem cells is remarkable. Still, there is a need for more research to tap more benefits of stem cell medicine. Jason Hope devotes his time and finances to philanthropic endeavors in the medical industry through organizations such as SENS. SENS is a research foundation that focuses on developing and testing treatments for aging. Instead of concentrating on treating diseases, SENS looks for ways to prevent the occurrence of a disease in the first place. Most of its research projects are related to stem cell intervention.